The DOI matches its Crossref record.
Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
Abstract
We have recently shown that oligodeoxynucleotides (ODN) containing unmethylated CpG dinucleotides (CpG motif) can induce B cells to proliferate, differentiate, and secrete cytokines. In this study we demonstrate that CpG motifs contained in ODN as short as 15 bases in length were quite effective at inducing NK cell lytic activity in vitro in both human and murine lymphocytes. Such ODN were also effective at inducing NK lytic activity, in vivo, in mice. Experiments designed to determine the cellular and cytokine requirements for NK cell induction revealed that B and T cells are not necessary, that the ODN do not augment the activity of highly purified NK cells, and that the ODN augment NK cell activity indirectly by inducing the secretion of IL-12, IFN-α β, and TNF-α. Various ODN sequences were prepared to determine the optimal ODN length, motif, palindrome, backbone modification, and dose requirements. We found no requirement for a palindromic sequence but a definite requirement for an unmethylated CpG motif. While necessary, however, a CpG motif was not sufficient for NK cell induction. Instead, there appeared to be stringent requirements for the immediate flanking bases at the 5' and 3' ends as well as for flanking sequences outside the immediate 5' and 3' bases. In particular poly(G) ends seemed to exert a complex qualitative and quantitative effect which could be up- or down-modulating depending on whether the ODN backbone was phosphorothioate modified or not.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Self-citationHornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Self-citationDNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Self-citationBode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Self-citationConverging Technologies for Improving Human Performance
(2003) · Springer eBooks · doi:10.1007/978-94-017-0359-8 · Cited by 794
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
Self-citationMoseman, E. A., Liang, X., Dawson, A. J., Panoskaltsis-Mortari, A., Krieg, A. M., Liu, Y.-J., Blazar, B. R., & Chen, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4433 · Cited by 637
Self-citationMechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
“rine dendritic cells (9, 10), murine NK cells (7, 11, 12), and murine”
BackgroundSelf-citationVollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324032 · Cited by 595
Self-citationHartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1617 · Cited by 585
Self-citationImmunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Self-citationJakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., & Vogel, J. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3042 · Cited by 541
Self-citationHuman Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs
Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2372 · Cited by 529
Innate and adaptive immunity in female genital tract: cellular responses and interactions
Wira, C. R., Fahey, J. V., Sentman, C. L., Pioli, P. A., & Shen, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00287.x · Cited by 520
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Self-citationSteinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 501
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2555 · Cited by 446
Self-citationLevin, A. A. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00140-2 · Cited by 438
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 397
Self-citationKrieg, A. M., Love-Homan, L., Yi, A.-K., & Harty, J. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2428 · Cited by 379
Self-citationAuchincloss, H., & Sachs, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.433 · Cited by 372
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3627 · Cited by 367
Millan, C. L. B., Weeratna, R., Krieg, A. M., Siegrist, C.-A., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15553 · Cited by 345
Self-citationThe role of CpG motifs in innate immunity
Krieg, A. M. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00048-5 · Cited by 343
Self-citationHuman lung cancer cells express functionally active Toll-like receptor 9
Droemann, D., Albrecht, D., Gerdes, J., Ulmer, A. J., Branscheid, D., Vollmer, E., Dalhoff, K., Zabel, P., & Goldmann, T. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-1 · Cited by 340
The Yin and Yang of Toll-like receptors in cancer
Pradere, J.-P., Dapito, D. H., & Schwabe, R. F. (2014) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 331
Yi, A.-K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4755 · Cited by 328
Self-citationBacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 314
Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
Moldoveanu, Z., Love-Homan, L., Huang, W. Q., & Krieg, A. M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80122-9 · Cited by 310
Self-citationUse of CpG oligodeoxynucleotides as immune adjuvants
Klinman, D. M., Currie, D., Gursel, I., & Verthelyi, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00148.x · Cited by 306
CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells
Liu, N., Ohnishi, N., Ni, L., Akira, S., & Bacon, K. B. (2003) · Nature Immunology · doi:10.1038/ni941 · Cited by 293
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 284
Kadowaki, N., Antonenko, S., & Liu, Y.-J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2291 · Cited by 280
Oblimersen Bcl-2 Antisense: Facilitating Apoptosis in Anticancer Treatment
Klasa, R. J., Gillum, A. M., Klem, R. E., & Frankel, S. R. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220798 · Cited by 280
Macfarlane, D. E., & Manzel, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1122 · Cited by 261
Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L., & Van Nest, G. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202630 · Cited by 259
CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.
Schwartz, D. A., Quinn, T. J., Thorne, P. S., Sayeed, S., Yi, A. K., & Krieg, A. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119523 · Cited by 254
Self-citationmRNA as gene therapeutic: How to control protein expression
Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232
CpG oligodeoxynucleotides as immunotherapy in cancer
Jahrsdörfer, B., & Weiner, G. J. (2008) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2007.11.003 · Cited by 132
Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112
Metadata
- Authors
- Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-09-01
- Volume
- 157
- Issue
- 5
- Pages
- 1840-1845
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1588809288
- Cited by
- 754
- References
- 0
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.